Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.83% | $3.19M | €358.72B | 39.25% | 76 Outperform | |
| Roche Holding AG | 1.96% | $2.21M | CHF250.59B | 35.86% | 73 Outperform | |
| AstraZeneca | 1.83% | $2.06M | £213.94B | 27.90% | 78 Outperform | |
| Novartis AG | 1.82% | $2.05M | CHF202.12B | 14.17% | 80 Outperform | |
| SAP SE | 1.65% | $1.86M | €242.59B | -10.16% | 66 Neutral | |
| HSBC Holdings | 1.56% | $1.76M | HK$1.92T | 46.27% | 79 Outperform | |
| Nestlé SA | 1.45% | $1.64M | CHF199.66B | 12.93% | 71 Outperform | |
| Banco Santander | 1.31% | $1.48M | €140.24B | 128.33% | 73 Outperform | |
| Shell (UK) | 1.29% | $1.46M | £159.60B | 9.10% | 74 Outperform | |
| Allianz | 1.21% | $1.36M | €140.80B | 24.58% | 67 Neutral |